BlackRock Discloses Passive 13G Stake in Seres Therapeutics
Ticker: MCRB · Form: SC 13G · Filed: Jan 29, 2024 · CIK: 1609809
| Field | Detail |
|---|---|
| Company | Seres Therapeutics, Inc. (MCRB) |
| Form Type | SC 13G |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-stake, 13G-filing
TL;DR
**BlackRock just revealed a big, passive stake in Seres Therapeutics.**
AI Summary
BlackRock Inc., a major investment firm, reported on January 29, 2024, that as of December 31, 2023, it holds a significant stake in Seres Therapeutics, Inc. (NASDAQ: MCRB) common stock. This filing indicates BlackRock's passive ownership, meaning they are not seeking to influence company management. For investors, this signals that a large, institutional investor sees value in Seres Therapeutics, potentially lending credibility to the stock, but also means a large block of shares is held by an entity that could sell them without warning.
Why It Matters
This filing shows that a major institutional investor, BlackRock, has a substantial, but passive, stake in Seres Therapeutics, which can be seen as a vote of confidence but also represents a large block of shares that could be sold.
Risk Assessment
Risk Level: low — A passive 13G filing from a large institutional investor like BlackRock generally indicates a stable, long-term holding without immediate intent to influence the company, posing low risk.
Analyst Insight
An investor should note BlackRock's passive stake as a potential sign of institutional confidence, but also recognize that this filing doesn't provide details on the size of the stake or any future intentions, warranting further research into Seres Therapeutics' fundamentals.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Seres Therapeutics, Inc. (company) — the subject company whose stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G
FAQ
What type of filing is this document?
This document is an SC 13G filing, specifically filed under Rule 13d-1(b), indicating a passive ownership stake by an institutional investor.
Which company is the subject of this filing?
The subject company of this filing is Seres Therapeutics, Inc., with CIK 0001609809.
Who is the reporting person in this SC 13G filing?
The reporting person is BlackRock Inc., with CIK 0001364742.
What is the CUSIP number for the securities mentioned in the filing?
The CUSIP number for the Common Stock of Seres Therapeutics, Inc. is 81750R102.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023.
Filing Details
This Form SC 13G (Form SC 13G) was filed with the SEC on January 29, 2024 regarding Seres Therapeutics, Inc. (MCRB).